| Price Range 12mo avg: | $2M – $2.5M |
|---|---|
| $/sf 12mo avg: | $318.75 |
| CAP Rate 12mo avg: | 7.29% |
| NOI average: | $173,700 |
| Lease Terms: | 15yrs NNN |
| Building Size avg: | 7,500 SF |
| Lot Size avg: | 2.5+/- acres |
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS)
Fresenius Medical Care is the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.7 million individuals worldwide. Through its network of 3,361 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 286,312 patients around the globe. Fresenius Medical Care is also the world’s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
| S&P Credit Rating: | BBB- |
|---|---|
| Moody’s Credit Rating: | Ba1 |
| Annual Revenue 2014: | $15.8B |
| Annual Revenue 2013: | $14.6B |
| Revenue Growth: | ↑ 8% from 2013 |
| Net Income | $1.05B |
| Units (Dec. 2014) | 3,361 |
| Average Units Volume: | $4.7M |
Yahoo! Finance: FMS News Latest Financial News for FMS
-
Fresenius Medical (FMS) is a “Dependable Top-Line Grower”, Says Fiduciary Management
on April 16, 2021 at 5:08 pm
Fiduciary Management Inc., an investment management firm, published its “International Equity” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 7.2% (currency hedged) was reported by the FMI International portfolios for the Q1 of 2021, compared to its MSCI EAFE benchmark that delivered a 7.59% return in [… […]
-
DaVita (DVA) Partners With Fresenius, Boost Home Dialysis Care
on March 29, 2021 at 1:00 pm
DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use. […]
-
'Unless we vaccinate the entire planet, we won't get rid of this pandemic:' Vaccine developer
on March 26, 2021 at 7:04 pm
Controversial billionaire scientist Dr. Patrick Soon-Shiong discusses COVID-19 vaccine efforts. […]
-
Attorneys Investigating Dialysis Company Over Treatment Disruptions, Medical Complications During February Arctic Blast in Texas
on March 9, 2021 at 5:31 pm
Kidney dialysis patients across East Texas may have failed to receive critical medical treatment due to communication failures at facilities owned by Fresenius Medical Care (NYSE: FMS). Attorneys at the nationally renowned Potts Law Firm and co-counsel at the firm of Derryberry Zips Wade are investigating reports that patients were not informed of attempts to reopen centers during recent Texas winter storm events, potentially leaving hundreds of patients without access to scheduled appointments. […]
-
Fresenius Medical Care Asia Pacific Continues to Forge Organization-Wide Inclusion and Diversity
on March 8, 2021 at 5:56 am
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has today launched its Asia Pacific Women’s Leadership Initiative (WLI) as a catalyst to continue driving inclusion and diversity (I&D) amongst its 13,000-strong workforce in the region. […]
NYSE: FMS
